Quantitative ultrasound (QUS) bone measurement is a promising, relativ
ely new technique for the diagnosis of osteoporosis. Unlike to the mor
e established method of bone densitometry [measurement of bone mineral
density (BMD) e.g. using dual X-ray absorptiometry (DEXA)], QUS does
not use ionizing radiation. It is cheaper, takes up less space and is
easier to use than densitometry techniques. The two QUS parameters cur
rently measured are broadband ultrasound attenuation (BUA) and speed o
f sound (SOS). The reported age-related changes for healthy women rang
e from -0.27% to -1.62% per year for BUA and from -0.06% to -0.19% per
year for SOS. Precision ranges from 1.0 to 3.8% (CV) for BUA and from
0.19 to 0.30% (CV) for SOS. The new method of imaging ultrasound has
improved the precision of QUS measurements. QUS is significantly corre
lated with BMD. Studies with the latest equipment have shown r-values
between 0.6 and 0.9 in site-specific measurements, and QUS is thus bel
ieved to reflect mainly BMD. However, other studies indicate that QUS
measures something other than the actual mineral content of bone, name
ly bone quality, e.g. in vitro studies have shown that QUS reflects tr
abecular orientation independently of BMD. In both cross-sectional and
prospective studies, QUS seems to be as good a predictor of osteoporo
tic fractures as BMD. In two large prospective studies, QUS also predi
cted fracture risk independently of BMD. QUS has just begun to be used
systematically for monitoring the response to anti-osteoporotic treat
ments in prospective trials. In the studies performed, QUS has been fo
und to be useful in the follow-up of patients. QUS is thus a promising
new technique for bone assessment.